Background. An increased incidence of end-stage renal disease (ESRD) in stroke patients has not been confirmed. The aim of this population-based study was to examine the risk of ESRD in stroke patients in Taiwan. Methods. We conducted a nationwide cohort study of 442 355 patients newly diagnosed with stroke, but without prior history of ESRD. Data were collected from Taiwan's National Health Insurance claims data during 2000-2008. Incidence and standardized incidence ratio (SIR) of ESRD were calculated using the general population of Taiwan as the reference. Results. Among all stroke patients, 7813 (1.77%) developed ESRD with a mean follow-up of 4.11 years. The SIR for ESRD was 2.78 [95% confidence interval (CI): 2.72-2.84] among stroke patients of all ages and was 22.73 (95% CI: 20.39-25.20) for patients aged 25-44 years. Male patients with stroke had a higher risk of ESRD (SIR: 2.94, 95% CI: 2.85-3.03) among stroke patients of all ages, and it was 23.41 (95% CI: 20.46-26.36) for male patients aged 25-44 years. Conclusions. Increased risk of ESRD in stroke patients is confirmed in Taiwan, and male patients between ages 25 and 44 years were at higher risk of ESRD compared with their counterparts in the general population. The clinical implication of our results is to closely monitor renal function in stroke patients, particularly those of younger age.
I N T R O D U C T I O N
The association between chronic kidney disease (CKD) and cardiovascular disease has been extensively explored [1, 2] . Studies have documented renal insufficiency as an independent predictor of both short-and long-term cardiovascular morbidity and mortality [3, 4] . Stroke is reported to be the third leading cause of mortality in the USA, and it has been defined as a rapid-onset central neurological deficit that either lasts for >24 h or results in death [5] . In Taiwan, stroke is the third leading cause of death, with a prevalence of 1.93% and incidence of 3.29% [6, 7] , and it accounted for 7.12% of all deaths in 2011 [8] . Considering that stroke and CKD share some risk factors, we believe that renal impairment is common among stroke patients and that stroke and CKD have similar pathologic mechanisms.
Although earlier studies in end-stage renal disease (ESRD) patients focused on the risk of coronary and related cardiac diseases, more recent studies have indicated that risk of stroke and related cerebrovascular diseases are also greatly increased in this population. This is consistent with a report from Seliger et al. [9] that the risk of hospitalized stroke was 5-10 times greater among maintenance dialysis patients compared with that in the general population. Epidemiological data have documented an association between kidney function and stroke risk [10, 11] . Consequently, CKD has numerous effects that may affect the neurological system and the development of stroke, including abnormal platelet function and volume overload [11] . In contrast with CKD, little is known about the progression of renal function to ESRD after stroke. Estimation of the incidence of ESRD in stroke patients is an essential step in assessing the clinical course and disease burden. However, few population-based epidemiological studies have examined the incidence of ESRD in association with stroke. Therefore, our study aimed to determine the incidence of ESRD in stroke patients by sex and age groups using the nationwide claims data of the National Health Insurance (NHI) program in Taiwan.
M AT E R I A L S A N D M E T H O D S

Data collection
Claims data of the NHI of Taiwan between 2000 and 2008 were collected for the purpose of retrospective study. The NHI program is a mandatory, compulsory, single-payer social health insurance system in which all citizens are obliged to participate. Implemented in 1995, NHI covered 99.5% of the population of Taiwan (23 million) by the end of 2008. The NHI research database has been released to researchers in an electronically encrypted form since 1999; this includes records of all medical benefit claims for ambulant care and inpatient care and is used extensively in epidemiological studies.
Because identification numbers of all individuals in the National Health Insurance Research databases were encrypted to protect the privacy of the individuals, this study was exempt from full review by the institution review board and informed consent was also not necessary.
Study population
Use of the NHI claims data allowed us to include 451 618 new-onset subjects (3 years washout with no ambulatory visits or hospitalization for stroke treatment) with primary stroke diagnosis (ICD-9-CM codes 430-437) who were older than the age of 25 years. To ensure the identity of the ESRD cases (ICD-9 code 585), we selected data from individuals who received their first ever issuance of ESRD certification during the period of 2000-2008 from the longitudinal catastrophic illness database of the NHI claims. Moreover, we excluded 9263 subjects due to missing data of age and/or sex, or who had a diagnosis of ESRD preceding stroke. Finally, the data from a total cohort of 442 355 subjects were used for analysis in this study ( Figure 1 ).
Statistical analysis
We first calculated the incidence of ESRD (cases per 1000 person-years) in patients with stroke by sex and age (25-44, 45-64 and ≥65 years). We performed all the analyses using SAS System for Windows, Version 8.2 (SAS Institute Inc., Cary, NC). To examine whether patients with stroke had a higher risk of developing ESRD, we computed the standardized incidence ratio (SIR) and its 95% confidence interval (CI) for ESRD in patients with stroke. The SIR, taken as the ratio of observed to expected number of ESRD cases, was used as a measure of relative risk, and 95% CIs were calculated after assuming a Poisson distribution of the observed number of ESRDs. The expected number of ESRD cases was estimated according to the incidence of ESRD among the general population matched for sex and age.
In order to clarify the effects on pre-existing diabetes, hypertension and CKD, we performed further stratified analyses of ESRD risks in stroke patients without such conditions. In addition, because different types of stroke may differ pathologically in relation to ESRD, we also conducted stratified analyses by the type of stroke.
R E S U LT S
Demographic and clinical characteristics of stroke patients are summarized in Table 1 . The cohort, comprising 442 355 patients with stroke, was analyzed with a mean follow-up of 4.11 years. Most patients were aged ≥65, and 57.7% of the study subjects were men. Overall, the incidence of ESRD during the observation period was 1.77%. Table 2 shows our estimates of the incidence of ESRD in stroke patients by gender and age groups. In total, 7813 people diagnosed with ESRD were identified during the observation period of 1 817 352 person-years, giving an overall incidence of 4.3 per 100 000 person-years (95% CI: 4.2-4.4) for the period of 2000-2008. The incidence was higher in female patients (4.6; 95% CI: 4.4-4.7) than in male patients (4.1; 95% CI: 4.0-4.2). The patterns of overall age-specific incidence followed a bellcurve trend line, with the incidence rate (per 100 000 personyears) of 3.1 in the youngest age group (25-44 years), rising rapidly to 5.6 in the 45-64 years age group, and then decreasing gradually to 3.7 in the oldest group (≥65 years). Table 3 shows the risk of ESRD in stroke patients. The SIR of ESRD in stroke patients of both sexes was significantly higher than in the general population (SIR: 2.78, 95% CI: 2.72-2.84). Among different age groups, the SIR of ESRD increased in younger (25-44 years) people of both sexes (SIR: 22.73, 95% CI: 20.39-25.20) and decreased in elderly (≥65 years) people of both sexes (SIR: 1.74, 95% CI: 1.68-1.79). The SIRs for ESRD categorized by sex for various age groups are illustrated in Table 3 .
Stratified analyses of risks for ESRD in stroke patients after excluding patients with prior diabetes, hypertension and CKD are shown in Table 4 . Male patients between age 25 and 44 were still at higher risk in comparison with their counterparts in the general population. Table 5 shows the risk of ESRD in different stroke types. We found that while the risks of ESRD were higher in young patients in all types of stroke in both sexes, the SIR of ESRD in young ischemic stroke patients was significantly higher than in the patients with hemorrhagic and unspecified stroke in both sexes.
D I S C U S S I O N
Over an 8-year follow-up period, we found that both male and female stroke patients in Taiwan experienced increased risk of ESRD. Although older age and being female tended to be 
O R I G I N A L A R T I C L E
I n c r e a s e d r i s k o f E S R D i n s t r o k e p a t i e n t s associated with higher incidence, being male, particularly being younger male within the 25-44 years age group, appeared to be associated with a notable increase in risk of ESRD. One of the strengths of this study has been that it was the first of its kind to use a nationwide population cohort, having the largest sample size compared with previous studies. This allowed us to calculate the incidence of ESRD among patients with stroke by sex-age group and to estimate the risk of ESRD in stroke patients in Taiwan. The incidence of ESRD in male stroke patients was lower than that of female stroke patients, except in those aged 25-44 years. In addition, higher incidence rates were found in women in older age groups (>45 years). Most previous studies that assessed incidence of stroke in ESRD patients, but not the incidence of ESRD in stroke patients [9, 12] , challenged the idea of making any direct comparisons between these two study objectives, which would include the present study.
In terms of age differences relating to the occurrence of ESRD among patients with stroke, it is expected that incidence would increase with age. However, when we compared the incidence of ESRD among patients with stroke with incidence among their sex-age group counterparts in the general population, we found that younger patients aged 25-44 had the highest risk of developing ESRD. The SIRs of ESRD tended to show an inverse relationship with age, and the largest SIR was observed in patients aged 25-44. Although patients with hemorrhagic and unspecified stroke appear to be less likely to develop ESRD than those with ischemic stroke and the average age of onset may vary across different types of stroke, we still found that patients of younger ages were at higher risks of developing ESRD after stratifying stroke patients by the type of stroke (Table 5) . Earlier stroke studies focusing on kidney function included mainly elderly patients, and in these studies, prevalence of kidney dysfunction in the young adult stroke population was either not reported or unknown. Because young adult patients with stroke have different risk factors and etiologic profiles from those of elderly stroke patients [13] , factors associated with impaired kidney function may also differ. In young stroke patients in Taiwan, there was a higher prevalence of small-vessel occlusion [14] . Previous study also showed that low glomerular filtration rate (GFR) is correlated with small-vessel disease in brain [11] . Although small-vessel occlusion is also common in older people, the relationship between low GFR and small-vessel disease was not contributed solely by conventional vascular risk factors. Genetic factors or specific etiology may participate in the pathogenesis because such relationship was just marginally modified by cardiovascular risk factors [11] . In addition, young stroke patients may have specific etiologies, such as vasculitis or vasculopathy, contributed to young stroke and also renal impairment. Therefore, it may explain partly the inverse relationship of age and ESRD in stroke patients.
Interestingly, we found that young people with stroke seemed to be at higher risk of future ESRD. Indeed, in Asian populations, hypertension is a major risk factor for both stroke and death from renal causes [15, 16] . CKD further increases the association of blood pressure with stroke [17] , and meta-analysis has shown that the risk of stroke associated with hypertension is consistently and significantly greater in Chinese than in Caucasians [18] . Furthermore, it has been suggested that Asian people tend to develop hypertension at earlier ages than other races [19] , and it is conceivable that a longer history of hypertension may cause more profound damage of end organs and vessels, thereby leading to a higher likelihood of vascular events within a given study period. These trends suggest that a further large-scale clinical follow-up study should be initiated in order to clarify the mechanisms involved in the high risk of developing ESRD among young male stroke patients.
The findings of the present study bring to light the possibility of a different pathophysiological process for stroke and ESRD. Stroke is typically associated with factors that promote atherosclerosis, including smoking, presence of diabetes, hypercholesterolemia and arterial hypertension [20] . These factors are also associated with CKD. We have not analyzed the data that explain directly the association between reduced kidney function and stroke, but other studies have revealed many potential pathological links [21] . However, our findings do show that this could also be different depending on the age, even after excluding patients with prior diabetes, hypertension or CKD (Table 4) . Additionally, the frequency of stroke in the Asian population is greater than in the Western population [22] , and stroke mortality in the Asian population is 3-fold higher than in Western populations [23] . Therefore, stroke prevention is an exceptionally important issue for Asian patients who have CKD.
Our study has several limitations that must be recognized. First, because our study used claim data that did not include some known risk factors for ESRD, including patients' lifestyle (e.g. smoking, alcoholism) and socioeconomic status, we were unable to adjust for these variables in the model. This may result in certain degrees of bias from potential confounders, which may reduce the reliability of our results. Second, ESRD and stroke diagnoses rely on administrative claims data reported by physicians or hospitals, which may be less accurate than diagnoses made according to standardized criteria. However, because the diagnosis of ICD-9 code 585 conveys a serious message to all patients, physicians generally avoid making such announcements without compatible laboratory reports of elevated serum creatinine [24] . Third, in order to identify incident patients of stroke, we applied a 3-year washout period, and there might be patients who had had previous episodes even earlier and thus were misidentified as incident (new) cases in our study. The number of such patients, however, should be small and thus unlikely to affect the conclusions. While other renal diseases or diseases with renal manifestations that were present prior to the stroke, including sickle cell, lupus/antiphospholipid syndrome, Fabry's disease, etc., might affect the results of our study because they might contribute to both stroke and CKD in the youngest patients, the number of such cases was small, and no remarkable changes were introduced to the study results when we excluded them from our analyses.
To our knowledge, this is the first analysis of epidemiological data on episodes of stroke in a large nationwide population-based study. Overall, our study findings confirmed that patients with stroke did have a higher risk of ESRD. Patients with stroke aged 25-44 years were at the highest risk of ESRD compared with their age and sex group counterparts in the general population. Further studies should be conducted to explore the underlying pathomechanisms and intervention strategies for patients experiencing stroke. 
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